FluoroPharma Medical Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.09 |
Market Cap |
$616.72 K |
Shares Outstanding |
34.26 M |
Public Float |
33.52 M |
Address |
8 Hillside Avenue Montclair New Jersey 07042 United States |
Employees | - |
Website | http://www.fluoropharma.com |
Updated | 07/08/2019 |
FluoroPharma Medical, Inc. engages in the research, development, and commercialization molecular imaging pharmaceuticals with initial applications in the area of cardiology. It focuses on the development of breakthrough positron emission tomography imaging agents for the efficient detection and assessment of acute and chronic forms of coronary artery disease. The company was founded on January 25, 2007 and is headquartered in Montclair, NJ. |